大庆华科(000985) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥482,819,586.36, a decrease of 23.26% compared to ¥629,173,594.69 in the same period last year[3] - Net profit attributable to shareholders increased by 61.66% to ¥3,674,785.42 from ¥2,273,226.83 year-on-year[3] - The net profit after deducting non-recurring gains and losses surged by 200.49% to ¥4,878,906.14 compared to ¥1,623,668.20 in the previous year[3] - Basic and diluted earnings per share increased by 55.56% to ¥0.028 from ¥0.018 year-on-year[3] - Net profit for Q1 2024 reached ¥3,674,785.42, representing a 61.6% increase from ¥2,273,226.83 in Q1 2023[13] Cash Flow and Liquidity - The net cash flow from operating activities rose by 35.97% to ¥31,620,128.89 from ¥23,254,404.49 in the same period last year[3] - Cash and cash equivalents increased to ¥336,208,944.19 from ¥311,039,784.58 at the beginning of the period, reflecting a growth of 8.1%[10] - Total cash and cash equivalents at the end of the period rose to ¥336,208,944.19 from ¥248,525,268.02, reflecting an increase of approximately 35.2%[16] - Operating cash inflow decreased to ¥609,995,258.38 from ¥721,515,486.55, a decline of approximately 15.5%[15] - The company’s cash flow from operating activities showed improvement, contributing to the increase in net profit despite lower revenues[13] Assets and Liabilities - Total assets at the end of the reporting period were ¥697,675,337.62, a slight decrease of 0.61% from ¥701,936,697.20 at the end of the previous year[3] - Total liabilities decreased to ¥108,292,096.09 from ¥115,879,760.43, a reduction of 6.5%[11] - Inventory decreased to ¥56,163,350.13 from ¥71,262,027.71, indicating a decline of 21.2%[10] - Shareholders' equity attributable to the parent company increased by 0.57% to ¥589,383,241.53 from ¥586,056,936.77 at the end of the previous year[3] Non-Recurring Items and Expenses - The company reported a non-recurring loss of ¥1,204,120.72, primarily due to non-current asset disposal losses[4] - The company reported a significant reduction in research and development expenses, which were ¥0.00 in Q1 2024 compared to ¥3,427,151.44 in Q1 2023[13] Shareholder Information - The total number of common shareholders at the end of the reporting period was 9,926[5] - The largest shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 55.03% of the shares[5] Future Outlook and Strategy - The company plans to focus on market expansion and new product development in the upcoming quarters to drive growth[13] - The company is expected to continue focusing on operational efficiency and cash flow management in the upcoming quarters[17] - No new products or technologies were mentioned in the report, indicating a potential area for future development[17] Audit and Reporting - The report was unaudited, suggesting that the figures may be subject to change upon final audit[16] - Cash flow from financing activities was not detailed in the report, indicating no significant changes in financing strategies[16] - The company did not report any net profit from subsidiaries prior to consolidation, maintaining a consistent performance in this area[14]